Medicines Co.

M&A

Novartis agrees to buy Medicines Co. in US$6.8 bil deal

(Nov 25): Novartis AG agreed to buy Medicines Co. for an equity value of about US$6.8 billion ($9.3 billion), snapping up a promising cholesterol drug and adding to a string of acquisitions for Chief Executive Officer Vas Narasimhan.
×